Enzolytics Inc. (ENZC)

USD 0.0

(7.69%)

Eps Summary of Enzolytics Inc.

  • Enzolytics Inc.'s latest annual eps in 2023 was -0.00 USD , up 30.0% from previous year.
  • Enzolytics Inc.'s latest quarterly eps in 2024 Q2 was - USD , up 100.0% from previous quarter.
  • Enzolytics Inc. reported an annual eps of -0.00 USD in 2022, down -400.0% from previous year.
  • Enzolytics Inc. reported an annual eps of -0.00 USD in 2021, up 94.44% from previous year.
  • Enzolytics Inc. reported a quarterly eps of - USD for 2024 Q2, up 100.0% from previous quarter.
  • Enzolytics Inc. reported a quarterly eps of -0.00 USD for 2023 Q3, down -100.0% from previous quarter.

Annual Eps Chart of Enzolytics Inc. (2023 - 2007)

Historical Annual Eps of Enzolytics Inc. (2023 - 2007)

Year Eps Eps Growth
2023 -0.00 USD 30.0%
2022 -0.00 USD -400.0%
2021 -0.00 USD 94.44%
2020 -0.00 USD -460.0%
2019 0.00 USD 122.22%
2018 -0.00 USD -1400.0%
2017 -0.00 USD 94.0%
2016 -0.01 USD 88.64%
2015 -0.04 USD 0.0%
2010 -541.66 USD -111.07%
2009 -256.63 USD -115.82%
2008 -118.91 USD 23.43%
2007 -155.29 USD 0.0%

Peer Eps Comparison of Enzolytics Inc.

Name Eps Eps Difference
Burzynski Research Institute, Inc. -0.01 USD 93.137%
Arch Therapeutics, Inc. -2.27 USD 99.969%
Evofem Biosciences, Inc. 10.35 USD 100.007%
Nascent Biotech, Inc. -0.01 USD 94.776%
Rebus Holdings, Inc. -0.03 USD 97.819%
Santhera Pharmaceuticals Holding AG 5.95 USD 100.012%
Qrons Inc. -0.06 USD 98.799%
Adynxx, Inc. - USD Infinity%
Neon Bloom, Inc. -0.00 USD 53.333%
Northwest Biotherapeutics, Inc. -0.06 USD 98.783%
ProtoKinetix, Incorporated -0.01 USD 93.0%
Skye Bioscience, Inc. -5.37 USD 99.987%
Eiger BioPharmaceuticals, Inc. -50.78 USD 99.999%
Nanobac Pharmaceuticals, Incorporated - USD Infinity%
Institute of Biomedical Research Corp. -0.05 USD 98.641%
SQZ Biotechnologies Company -2.76 USD 99.975%
Intellipharmaceutics International Inc. -0.09 USD 99.199%
Propanc Biopharma, Inc. -0.02 USD 97.046%
Mesoblast Limited -0.09 USD 99.214%
Marizyme, Inc. -1.44 USD 99.951%
Genus plc 0.12 USD 100.583%
VioQuest Pharmaceuticals, Inc. -2.33 USD 99.97%
Pharming Group N.V. -0.02 USD 95.652%
Therapeutic Solutions International, Inc. -0.00 USD -0.0%
CNBX Pharmaceuticals Inc. -0.42 USD 99.833%
Nymox Pharmaceutical Corporation -0.10 USD 99.275%
ContraFect Corporation -124.97 USD 99.999%
PsyBio Therapeutics Corp. -0.04 USD 98.333%
Sienna Biopharmaceuticals, Inc. - USD Infinity%
RegeneRx Biopharmaceuticals, Inc. -0.01 USD 94.167%
IMV Inc. -4.37 USD 99.984%
AXIM Biotechnologies, Inc. -0.04 USD 98.023%
MultiCell Technologies, Inc. -0.00 USD -600.0%
ONE Bio Corp. 1.43 USD 100.049%
Accustem Sciences Inc. -0.34 USD 99.794%
RVL Pharmaceuticals plc -0.58 USD 99.879%
Arno Therapeutics, Inc. - USD Infinity%
EV Biologics, Inc. -0.12 USD 99.417%
Q BioMed Inc. -0.08 USD 99.104%
Emmaus Life Sciences, Inc. -0.07 USD 99.004%
Mosaic ImmunoEngineering Inc. -0.33 USD 99.788%
Biomind Labs Inc. -0.02 USD 95.679%
American Oriental Bioengineering, Inc. -781.24 USD 100.0%
Provectus Biopharmaceuticals, Inc. -0.01 USD 90.541%
TetraLogic Pharmaceuticals Corporation - USD Infinity%
Oncotelic Therapeutics, Inc. -0.02 USD 96.482%
GlobeStar Therapeutics Corporation -0.00 USD 70.833%
THC Farmaceuticals, Inc. -0.00 USD 12.5%
Acro Biomedical Co., Ltd. -0.26 USD 99.731%
Curative Biotechnology, Inc. -0.01 USD 92.045%
GB Sciences, Inc. -0.00 USD 82.927%
Alpha Cognition Inc. -0.15 USD 99.533%
HST Global, Inc. -0.03 USD 97.491%
CSL Limited 2.73 USD 100.026%
Wesana Health Holdings Inc. -0.05 USD 98.603%
Halberd Corporation -0.00 USD -600.0%
Agentix Corp. -0.04 USD 98.0%
Resverlogix Corp. -0.01 USD 95.07%
Nuo Therapeutics, Inc. -0.08 USD 99.072%
MetaStat, Inc. - USD Infinity%
argenx SE -5.16 USD 99.986%
Enzon Pharmaceuticals, Inc. 0.00 USD 153.846%
Endonovo Therapeutics, Inc. 0.03 USD 102.789%
RespireRx Pharmaceuticals Inc. -0.04 USD 98.039%
GeneThera, Inc. - USD Infinity%
Inhibitor Therapeutics, Inc. -0.02 USD 96.5%
AVAX Technologies, Inc. -0.05 USD 98.701%
Zenith Capital Corp. -0.07 USD 98.999%
Genscript Biotech Corporation -0.05 USD 98.458%
Ember Therapeutics, Inc. -0.01 USD 88.889%
Anthera Pharmaceuticals, Inc. - USD Infinity%
Sigyn Therapeutics, Inc. -3.77 USD 99.981%
WPD Pharmaceuticals Inc. -0.00 USD -40.0%
Cotinga Pharmaceuticals Inc. -0.09 USD 99.233%
Kadimastem Ltd -0.78 USD 99.91%
Helix BioMedix, Inc. -4.70 USD 99.985%
VitaSpring Biomedical Co. Ltd. - USD Infinity%
Capstone Therapeutics Corp. -36.39 USD 99.998%
BioStem Technologies, Inc. -0.62 USD 99.887%
Oncology Pharma Inc. - USD Infinity%
Reve Technologies, Inc. -0.01 USD 94.118%
LadRx Corporation 0.68 USD 100.103%
Cell Source, Inc. -0.17 USD 99.588%
Regen BioPharma, Inc. 0.29 USD 100.241%
Regen BioPharma, Inc. 0.26 USD 100.269%
NovAccess Global Inc. -0.23 USD 99.696%
Affymax, Inc. -0.39 USD 99.821%
Itoco Inc. -0.01 USD 90.789%
Rasna Therapeutics, Inc. -0.01 USD 93.0%
Pathfinder Cell Therapy, Inc. -0.00 USD 72.0%
Mobile Lads Corp. -0.01 USD 87.5%
CytoDyn Inc. -0.05 USD 98.677%
Claritas Pharmaceuticals, Inc. - USD Infinity%
NDT Pharmaceuticals Inc. -0.00 USD -40.0%
NanoSphere Health Sciences Inc. -0.02 USD 96.847%
Alseres Pharmaceuticals, Inc. -153.67 USD 100.0%
SYBLEU INC -0.02 USD 96.0%
Advanced Proteome Therapeutics Corporation - USD Infinity%
ImmunoCellular Therapeutics, Ltd. -0.01 USD 95.07%
International Stem Cell Corporation -0.02 USD 95.732%
Bioxytran, Inc. -0.03 USD 97.806%
GlobeImmune, Inc. - USD Infinity%
Predictive Technology Group, Inc. - USD Infinity%
ProText Mobility, Inc. - USD Infinity%
Cardax, Inc. - USD Infinity%
VG Life Sciences Inc. -0.00 USD -600.0%
Kaleido Biosciences, Inc. - USD Infinity%
Advaxis, Inc. -7.99 USD 99.991%
Adhera Therapeutics, Inc. -1.18 USD 99.941%
RenovaCare, Inc. - USD Infinity%
Regnum Corp. -0.03 USD 97.941%
Innovation Pharmaceuticals Inc. -0.01 USD 88.889%
Neutra Corp. -0.00 USD -600.0%
Windtree Therapeutics, Inc. -94.23 USD 99.999%
PureTech Health plc -2.38 USD 99.971%
Coeptis Therapeutics, Inc. -0.83 USD 99.916%
IXICO plc -0.02 USD 97.131%
IntelGenx Technologies Corp. -0.06 USD 98.768%
Gelesis Holdings, Inc. -1.35 USD 99.948%
CSL Limited 5.47 USD 100.013%
Cellectis S.A. -1.77 USD 99.96%